THE US Food and Drug
Administration is in the process of
drawing up guidelines for the
possible regulation and oversight of
smartphone medical Apps.
The review is timely given the
FDAs estimation that by 2015 more
than 500 million smartphone users
across the globe will have at least
one health care application.
According to the FDA, its
oversight will look at a specific
group of apps which “present the
greatest risk to patients when they
don’t work as intended” including
apps that are used as an accessory
to medical devices already
regulated by the FDA and apps
that transform a mobile
communications device into a
regulated medical device.The above article was sent to subscribers in Pharmacy Daily's issue from 20 Jul 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 20 Jul 11
MAYNE Pharma Group Limited has filed a patent infringement suit against Sun Pharmaceutical Industries Ltd and Inc., in the United States District Court, according to yesterday’s ASX announcement.
PHARMACY Connect 2024 conference will feature a provocative ‘Great Debate’ during the Harm Minimisation Workshop on Thu 05 Sep at the Hyatt Regency in Sydney.
LTR Pharma Limited has successfully raised $10.5 million through a share placement to sophisticated and new institutional investors, significantly surpassing initial demand.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.